CDFD Technology Incubator reposted this
🌟 Discovery Research at 𝐂𝐚𝐧𝐜𝐞𝐫 𝐍𝐄𝐗𝐓 𝟐𝟎𝟐𝟒🌟 The journey into cutting-edge advancements in oncology continued with Session 2: Discovery Research, chaired by two distinguished experts: Dr. Ajith Kamath, EC Member, Federation of Asian Biotech Associations (FABA), and Dr. M. Sreenivasulu, Director, MNJ Hospital. This session brought to light some of the most promising innovations in cancer research and therapeutics. Dr Uday Saxena, CHAIR – Product Development, Bharat Advanced Therapeutics, expressed the need for a drug that can inhibit existing oncogenes and new mutations to avoid relapse. He stressed that cancer patients are waiting for new therapies and every delay is a life lost. Speaking on Bispecific Antibodies, Dr. Murali Ramachandra, CEO, Aurigene Oncology Limited, spoke on the company’s goal to engage in sustainable drug discovery with pharma partners. Dr. Benu Brata Das, Professor at the Indian Association for the Cultivation of Science, spoke on research on mitochondrial DNA damage, cancer therapeutics, and the role of specific molecular pathways and inhibitors. Dr Murali Dharan Bashyam, Head, Lab of Molecular Oncology, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), outlined potential targeted therapies for cancer, focusing on oncogenes, tumour suppressor genes, and chromatin remodelling complexes. Harish Sharma from the Serum Institute of India Pvt. Ltd. highlighted the groundbreaking potential of Cervavac, the institute's cervical cancer vaccine. He emphasised that Cervavac marks a significant advancement in India’s fight against cervical cancer, offering both widespread accessibility and the promise of impactful public health outcomes. These discussions underscored the importance of collaborative research and the potential of these strategies to transform cancer treatment. By highlighting diverse therapeutic approaches, the session emphasised the critical need for precision and innovation in addressing complex oncological challenges. Follow Bharath Advanced Therapeutics for more updates on the conference! #CancerNEXT2024 #CancerTreatment #InnovativeTherapeutics #CollaborationForCure #BharathAdvancedTherapeutics #CancerConference #Conference #CancerResearch #DrugDevelopment #Innovation Dr. Markandeya Gorantla Sreedhara R. Voleti Dr. Mamta S.K, Ph.D. Ranjana Sarma Suresh Poosala Bharat Kumar Sarvepalli Jaganmohan Reddy Venkata Sasidhar Manda Dr Sudha S Murthy CDFD Technology Incubator Smruthi Suryaprakash Department of Biotechnology DBT BIRAC Startup India Telangana Innovation Cell Telangana Lifesciences Sreedhar AS Centre for Cellular and Molecular Biology Aurigene Oncology Limited Sunil Kumar Manna Suraj Bhansali Dr. T . Roshni Paul Raghunadharao Digumarti NATCO Pharma Virchow Biotech ImmunoACT
-
+1